4//SEC Filing
Fisher Clare 4
Accession 0001415889-25-010439
CIK 0001656634other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 8:59 PM ET
Size
12.7 KB
Accession
0001415889-25-010439
Insider Transaction Report
Form 4
Fisher Clare
Director
Transactions
- Other
Stock Option (Right to Buy)
2025-04-04−38,000→ 0 totalExercise: $12.86Exp: 2031-12-31→ Common Stock (38,000 underlying) - Other
Stcok Option (right to buy)
2025-04-04−8,693→ 0 totalExercise: $2.22Exp: 2032-06-21→ Common Stock (8,693 underlying) - Other
Stock Option (Right to Buy)
2025-04-04−51,800→ 0 totalExercise: $2.19Exp: 2033-06-15→ Common Stock (51,800 underlying) - Other
Stock Option (Right to Buy)
2025-04-04−51,800→ 0 totalExercise: $0.76Exp: 2034-06-16→ Common Stock (51,800 underlying)
Footnotes (3)
- [F1]Pursuant to the Issuer's Second Modified Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code, which was confirmed by the United States Bankruptcy Court for the District of Delaware on April 3, 2025 and became effective on April 4, 2025, each share of the Issuer's common stock and options to purchase the Issuer's common stock outstanding prior to the Issuer's emergence from bankruptcy were cancelled for no value.
- [F2]The options are fully vested.
- [F3]The option will vest and become exercisable on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through the applicable vesting date.
Documents
Issuer
Gritstone bio, Inc.
CIK 0001656634
Entity typeother
Related Parties
1- filerCIK 0001901917
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 8:59 PM ET
- Size
- 12.7 KB